Opendata, web and dolomites

REGENERA

REGENERATING NATURAL AESTHETICS

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 REGENERA project word cloud

Explore the words cloud of the REGENERA project. It provides you a very rough idea of what is the project "REGENERA" about.

carcinogenic    contracture    channels    rest    innovative    drawbacks    original    distinctive    subsequently    manufactured    approximately    silicone    biomaterials    adipose    replicating    clinics    replaces    limited    decrease    induce    patented    appearance    drastically    undergo    risks    tissue    implants    prosthesis    maturation    lumpectomy    procedure    regenera    leakage    requiring    mammary    combination    healthcare    occupied    larger    permanently    autotransplantation    temporary    substitution    stable    shape    synthetic    every    reconstructions    mastectomy    quality    micro    alternative    size    surgical    biodegradable    augmentation    breast    internal    biocompatible    degrade    defects    rupture    operations    pain    life    30    natural    ca    blood    complete    adipocytes    technique    architecture    million    properly    vessels    globally    promotes    reconstructive    porous    volume    volumes    interventions    filled    capsular    reduce    incidence    fat    ingrowth    small    surgery    reconstructed    multiple    regeneration    people    patients    patient    restoring   

Project "REGENERA" data sheet

The following table provides information about the project.

Coordinator
TENSIVE SRL 

Organization address
address: VIA TIMAVO 34
city: MILANO
postcode: 20124
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Italy [IT]
 Project website http://www.tensivemed.com
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.2.1.5. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Advanced manufacturing and processing)
2. H2020-EU.2.1.3. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Advanced materials)
3. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument)
4. H2020-EU.2.1.2. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies – Nanotechnologies)
 Code Call H2020-SMEINST-1-2016-2017
 Funding Scheme SME-1
 Starting year 2016
 Duration (year-month-day) from 2016-08-01   to  2017-01-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    TENSIVE SRL IT (MILANO) coordinator 50˙000.00

Map

 Project objective

Every Year, globally ca. 0.8 million people experience reconstructive surgery after mastectomy or lumpectomy and 1.2 million undergo breast augmentation surgery. Currently, breast defects are not properly reconstructed but only temporary filled with silicone implants, which however present several drawbacks such as the need of substitution after approximately 10 years, rupture (30% of incidence), leakage and capsular contracture. An alternative procedure that is currently available in clinics is fat autotransplantation. However, this technique presents potential carcinogenic risks and is still limited to small volumes, requiring multiple interventions to achieve larger reconstructions. REGENERA is an innovative mammary prosthesis based on biodegradable, porous, synthetic biomaterials and manufactured with internal micro-channels replicating the blood-vessels architecture. This distinctive combination, obtained by a patented process, promotes the natural fat growth, and allows the regeneration of a large adipose tissue volume. REGENERA’s overall objective is to improve patients’ quality of life, by restoring permanently the breast’s natural shape, appearance and size following a mastectomy/lumpectomy. Moreover, since REGENERA does not require further surgical operations for the rest of the patient’s life, it can drastically reduce the pain of the patient and decrease the associated Healthcare costs. REGENERA specific objective is to provide a biocompatible support able to induce the ingrowth of adipocytes and subsequently degrade, allowing the complete maturation of a stable adipose tissue, that replaces the original volume occupied by the prosthesis.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "REGENERA" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "REGENERA" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.2.1.5.;H2020-EU.2.1.3.;H2020-EU.2.3.1.;H2020-EU.2.1.2.)

SUPPLEPRINT (2018)

Super Productive Line Printing Inkjet

Read More  

HelpingHAND (2018)

A 3D printed, affordable myoelectrical prosthetic hand of personalizeable size for optimal comfort and functionality

Read More  

HIL PT System (2017)

Revolutionary, cost effective, spatially efficient, proton therapy system for cancer treatment.

Read More